| |
| |
|
| Insider
Information: |
Loy Bertrand |
| Relationship: |
Director |
| City: |
Acton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
323,083 |
|
|
Indirect Shares
|
499,633 |
|
|
| Direct
Value |
$33,417,985 |
|
|
|
Indirect Value
|
$1,583,837 |
|
|
| Total
Shares |
822,716 |
|
|
| Total
Value |
$35,001,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
|
Harvard Bioscience Inc |
HBIO |
Director |
2024-05-21 |
56,575 |
2024-05-21 |
499,633 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2021-08-11 |
4 |
AS |
$116.04 |
$2,766,024 |
I/I |
(23,710) |
0 |
0 |
% |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,248 |
201,348 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-02-11 |
4 |
D |
$124.48 |
$1,326,085 |
D/D |
(10,653) |
214,715 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
24,020 |
225,368 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-02-18 |
4 |
D |
$130.19 |
$1,958,448 |
D/D |
(15,043) |
199,672 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
116 |
199,788 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-08-15 |
4 |
D |
$105.39 |
$986,134 |
D/D |
(9,357) |
190,431 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
51,292 |
241,723 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2023-02-13 |
4 |
D |
$84.94 |
$741,271 |
D/D |
(8,727) |
252,672 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
19,676 |
261,399 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2023-02-17 |
4 |
D |
$85.48 |
$1,207,490 |
D/D |
(14,126) |
238,546 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2023-08-15 |
4 |
D |
$95.87 |
$897,056 |
D/D |
(9,357) |
229,189 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2024-02-16 |
4 |
D |
$136.81 |
$2,155,578 |
D/D |
(15,756) |
213,433 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2024-02-20 |
4 |
D |
$136.81 |
$1,245,929 |
D/D |
(9,107) |
224,860 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2024-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,534 |
233,967 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,208 |
263,068 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
14,400 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,800 |
26,200 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,700 |
52,900 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,600 |
70,500 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
31,300 |
101,800 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
117,750 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
135,850 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
149,850 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
35,100 |
184,950 |
0 |
- |
|
177 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
